A new study published in the journal Cell Metabolism strongly suggests that low doses of weight loss drugs like Ozempic and Zepbound can counteract aging in middle-aged mice, adding to the growing suspicion that these medications might also increase human longevity.

The team of researchers, led by the Chinese University of Hong Kong, set out to develop possible methods to counteract aging by focusing on the effectiveness of exenatide, a type of glucagon-like peptide-1 receptor agonist or GLP-1RA that’s similar to Ozempic; the medication is used to control blood sugar in diabetics by activating the protein GLP-1 receptor, which increases insulin in the blood stream and lessens appetite.

They took 18 middle aged mice, about 10 to 14 months old, and divided them into two groups: one cohort

See Full Page